Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report

23 Mar 2020

Abstract excerpt

Cervical cancer is the fourth most common cancer in women worldwide, and prognosis is poor for those who experience recurrence or develop metastatic disease, in part due to the lack of active therapeutic directions. The National Cancer Institute convened a Cervical Cancer Clinical Trials Planning Meeting in October 2018 to facilitate the design of hypothesis-driven clinical trials focusing on locally advanced,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Lung Cancer Treatments and Mutations
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32219419
DOI: 10.1093/jnci/djaa041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting ReportPMID 32219419Read ↗

Breaking the DNA damage response to improve cervical cancer treatment.Semantic proximity Read ↗

A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.Semantic proximity Read ↗

The research progress on radiation resistance of cervical cancerSemantic proximity Read ↗

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.Semantic proximity Read ↗

A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencingSemantic proximity Read ↗

Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target ApproachSemantic proximity Read ↗

Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinomaSemantic proximity Read ↗

DNA Damage and Its Role in Cancer Therapeutics.Semantic proximity Read ↗

Repurposing DNA repair factors to eradicate tumor cells upon radiotherapySemantic proximity Read ↗

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer TherapiesSemantic proximity Read ↗

Epigenetics and cervical cancer: from pathogenesis to therapySemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.